| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |